Side Effects of Rapamycin in the Rat

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Ocular Pharmacology and Therapeutics

• Publication date

  1995-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/jop.1995.11.177PMID 8564638
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of cellular transfer of experimental autoimmune uveoretinitis by Rapamycin.

  1993cited by this paper
• A clinical trial of FK506 in refractory uveitis.

  1993cited by this paper
• Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transduction.

  1993cited by this paper
• The regeneration of transplanted hepatocytes within the mesenteric fat pad of mice.

  1993cited by this paper
• Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production.

  1991cited by this paper
• Reversal of ongoing rejection of allografts by rapamycin.

  1991cited by this paper
• Toxicity of rapamycin--a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat.

  1991cited by this paper
• Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat.

  1991cited by this paper
• Inhibition of skin graft rejection in mice by rapamycin: a novel immunosuppressive macrolide.

  1991cited by this paper
• Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.

  1990cited by this paper
• Toxicologic evaluation of FK 506.

  1990cited by this paper
• Renal histopathologic alterations in patients treated with cyclosporine for uveitis.

  1986cited by this paper

• Recent drug therapies for corneal neovascularization

  2017cites this paper
• Co-transplantation of syngeneic mesenchymal stem cells improves survival of allogeneic glial-restricted precursors in mouse brain.

  2016cites this paper
• Effect of Chronic Administration of Low Dose Rapamycin on Development and Immunity in Young Rats

  2015cites this paper
• Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.

  2010cites this paper
• Polylactide-glycoli acid and rapamycin coating intraocular lens prevent posterior capsular opacification in rabbit eyes

  2009cites this paper
• In-vitro drug release from biodegradable matrices : analysis, modeling and application in vascular stents

  2008cites this paper
• Synergistic Suppression of Rat Neointimal Hyperplasia by Rapamycin and Imatinib Mesylate: Implications for the Prevention of Accelerated Arteriosclerosis

  2006cites this paper
• Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways.

  2003cites this paper
• Stent‐based antirestenotic coatings (sirolimus/paclitaxel)

  2002cites this paper
• Cardiac Allograft Rejection

  2001cites this paper
• New Immunosuppressive Agents

  2001cites this paper
• Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future.

  2000cites this paper
• Newer immunosuppressive drugs: a review.

  1999cites this paper
• Tacrolimus-rapamycin combination therapy for experimental autoimmune uveoretinitis.

  1997cites this paper